Mesoblast Ltd is a biotechnology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MEOBF is expected to report earnings to rise 166.67% to -3 cents per share on August 27
Q2'25
Est.
$-0.04
Q4'24
Est.
$-0.01
Q3'24
Est.
$-0.01
Q4'23
Est.
$-0.02
Q3'23
Est.
$-0.02
The last earnings report on February 26 showed earnings per share of -1 cents, meeting the estimate of -1 cents. With 500.00 shares outstanding, the current market capitalization sits at 1.91B.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MEOBF showed earnings on February 26, 2025. You can read more about the earnings report here.